Gene Logic Inc. (NASDAQ:GLGC) announced today the appointment of Mark T. Crane as vice president, Marketing and Business Development for Gene Logic's Preclinical Division. Mr. Crane is an industry veteran who brings extensive sales and marketing leadership experience from Quest Pharmaceutical Services, MDS Pharma Services, Avantec, and PerkinElmer. In his new position with Gene Logic, Mr. Crane is responsible for sales and marketing of preclinical services to pharmaceutical and biotechnology companies and to government organizations. "Gene Logic is pleased to recruit Mark Crane, a proven leader with a track record of increasing sales for life science companies," said V.W. Brinkerhoff III, senior vice president and general manager, Gene Logic Laboratories. "Mark knows the preclinical business, knows our clients, and understands their needs. His strong background in sales and marketing will guide our outreach to new biotechnology clients, and help us expand our business with pharmaceutical clients." Gene Logic Overview Gene Logic is leading the transformation of pharmaceutical research and development with its extensive gene expression databases, pioneering efforts in toxicogenomics, sophisticated bioinformatics expertise, specialty nonclinical services testing capabilities and cutting edge technology program for drug repositioning. Gene Logic technologies and services are used by many of the world's top pharmaceutical and biotechnology companies. Over 150 organizations and government agencies have benefited from Gene Logic's diverse portfolio of drug development services, enabling them to make more informed, more reliable and more predictive decisions at each point in the highly complex and costly drug development process. Founded in 1994, Gene Logic is headquartered in Gaithersburg, Md., with additional research and development facilities in Cambridge, Mass. and Berkeley, Calif. The Company maintains customer support operations in Europe and Asia and currently has about 450 employees worldwide. For more information, visit www.genelogic.com or call toll-free - 1/800/GENELOGIC.
Gene Logic Inc. (MM) (NASDAQ:GLGC)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Gene Logic Inc.  (MM) Charts.
Gene Logic Inc. (MM) (NASDAQ:GLGC)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Gene Logic Inc.  (MM) Charts.